What condition leads to a deficiency in factor IX that can be corrected by an intravenous injection of vitamin K?

  1. Docea AO, Gofiță E, Călina D, Zaharie SI, Vâlcea DI, Mitruț P. Autoimmune disorders due to double antiviral therapy with Peginterferon and Ribavirin in patients with hepatitis C virus infection. Farmacia. 2016;64(4):605–61185.

    Google Scholar 

  2. Link KP. The discovery of dicumarol and its sequels. Circulation. 1959;19:97–107.

    CAS  Article  PubMed  Google Scholar 

  3. Bye A, King HK. The biosynthesis of 4-hydroxycoumarin and dicoumarol by Aspergillus fumigatus Fresenius. Biochem J. 1970;117:237–45.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Diener HC, Connolly SJ, Ezekowitz MD, Wallentin L, Reilly PA, Yang S, Xavier D, Di Pasquale G, Yusuf S, group R-Ls. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol. 2010;9:1157–63.

    CAS  Article  PubMed  Google Scholar 

  5. Turpie AG, Lassen MR, Eriksson BI, Gent M, Berkowitz SD, Misselwitz F, Bandel TJ, Homering M, Westermeier T, Kakkar AK. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Thromb Haemost. 2011;105:444–53.

    CAS  Article  PubMed  Google Scholar 

  6. Raskob GE, Gallus AS, Pineo GF, Chen D, Ramirez LM, Wright RT, Lassen MR. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg (Br). 2012;94:257–64.

    CAS  Article  Google Scholar 

  7. Saffian SM, Duffull SB, Roberts RL, Tait RC, Black L, Lund KA, Thomson AH, Wright DF. Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool. Ther Drug Monit. 2016;38:677–83.

    CAS  Article  PubMed  Google Scholar 

  8. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G, American College of Chest P. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e44S–88S.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH, American College of Chest P. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e152S–84S.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. Ageno W, Crowther M, Steidl L, Ultori C, Mera V, Dentali F, Squizzato A, Marchesi C, Venco A. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Thromb Haemost. 2002;88:48–51.

    CAS  PubMed  Google Scholar 

  11. Hambleton J, Wages D, Radu-Radulescu L, Adams M, MacKenzie M, Shafer S, Lee M, Smyers J, Wiesehahn G, Corash L. Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin. Transfusion. 2002;42:1302–7.

    CAS  Article  PubMed  Google Scholar 

  12. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006;126:133–9.

    Article  PubMed  Google Scholar 

  13. Makris M, Watson HG. The management of coumarin-induced over-anticoagulation Annotation. Br J Haematol. 2001;114:271–80.

    CAS  Article  PubMed  Google Scholar 

  14. Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. Br J Surg. 2000;87:266–72.

    CAS  Article  PubMed  Google Scholar 

  15. Spahr JE, Maul JS, Rodgers GM. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol. 2007;82:656–60.

    CAS  Article  PubMed  Google Scholar 

  16. Kruse JA, Carlson RW. Fatal rodenticide poisoning with brodifacoum. Ann Emerg Med. 1992;21:331–6.

    CAS  Article  PubMed  Google Scholar 

  17. Huic M, Francetic I, Bakran I, Macolic-Sarinic V, Bilusic M. Acquired coagulopathy due to anticoagulant rodenticide poisoning. Croat Med J. 2002;43:615–7.

    PubMed  Google Scholar 

  18. DeClementi C, Sobczak BR. Common rodenticide toxicoses in small animals. Vet Clin North Am Small Anim Pract. 2012;42:349–60. viii.

    Article  PubMed  Google Scholar 

  19. Lee HJ, You MR, Moon WR, Sul H, Chung CH, Park CY, Park SG. Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum. Korean J Intern Med. 2014;29:498–508.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wu YF, Chang CS, Chung CY, Lin HY, Wang CC, Shen MC. Superwarfarin intoxication: hematuria is a major clinical manifestation. Int J Hematol. 2009;90:170–3.

    CAS  Article  PubMed  Google Scholar 

  21. Franco D, Everett G, Manoucheri M. I smell a rat: a case report and literature review of paradoxical thrombosis and hemorrhage in a patient with brodifacoum toxicity. Blood Coagul Fibrinolysis. 2013;24:202–4.

    PubMed  Google Scholar 

  22. Abell TL, Merigian KS, Lee JM, Holbert JM, McCall 3rd JW. Cutaneous exposure to warfarin-like anticoagulant causing an intracerebral hemorrhage: a case report. J Toxicol Clin Toxicol. 1994;32:69–73.

    CAS  Article  PubMed  Google Scholar 

  23. Zupancic-Salek S, Kovacevic-Metelko J, Radman I. Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII. Blood Coagul Fibrinolysis. 2005;16:239–44.

    CAS  Article  PubMed  Google Scholar 

  24. Gunja N, Coggins A, Bidny S. Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels. Clin Toxicol (Phila). 2011;49:385–90.

    CAS  Article  Google Scholar 

  25. Saja MF, Abdo AA, Sanai FM, Shaikh SA, Gader AG. The coagulopathy of liver disease: does vitamin K help? Blood Coagul Fibrinolysis. 2013;24:10–7.

    CAS  Article  PubMed  Google Scholar 

  26. Chua JD, Friedenberg WR. Superwarfarin poisoning. Arch Intern Med. 1998;158:1929–32.

    CAS  Article  PubMed  Google Scholar 

  27. Litovitz TL, Klein-Schwartz W, Rodgers Jr GC, Cobaugh DJ, Youniss J, Omslaer JC, May ME, Woolf AD, Benson BE. Annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 2001;2002(20):391–452.

    Google Scholar 

  28. Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Omslaer JC, Drab A, Benson BE. Annual report of the American Association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 2000;2001(19):337–95.

    Google Scholar 

  29. Watson WA, Litovitz TL, Rodgers Jr GC, Klein-Schwartz W, Youniss J, Rose SR, Borys D, May ME. Annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 2002;2003(21):353–421.

    Google Scholar 

  30. Zhao SL, Li P, Ji M, Zong Y, Zhang ST. Upper gastrointestinal hemorrhage caused by superwarfarin poisoning. World J Gastroenterol. 2010;16:1680–2.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. Boettcher S, Wacker A, Moerike K, Kopp HG, Jaschonek K, Grobosch T, Kanz L, Salih HR. Acquired coagulopathy caused by intoxication with the superwarfarin-type anticoagulant rodenticide flocoumafen. Eur J Haematol. 2011;86:173–5.

    CAS  Article  PubMed  Google Scholar 

  32. Watson WA, Litovitz TL, Rodgers Jr GC, Klein-Schwartz W, Reid N, Youniss J, Flanagan A, Wruk KM. Annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 2004;2005(23):589–666.

    Google Scholar 

  33. Iber FL. Drug metabolism in heavy consumers of ethyl alcohol. Clin Pharmacol Ther. 1977;22:735–42.

    CAS  Article  PubMed  Google Scholar 

  34. King N, Tran MH. Long-acting anticoagulant rodenticide (Superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management. Transfus Med Rev. 2015;29:250–8.

    Article  PubMed  Google Scholar 

  35. Babcock J, Hartman K, Pedersen A, Murphy M, Alving B. Rodenticide-induced coagulopathy in a young child. A case of Munchausen syndrome by proxy. Am J Pediatr Hematol Oncol. 1993;15:126–30.

    CAS  Article  PubMed  Google Scholar 

  36. Stanziale SF, Christopher JC, Fisher RB. Brodifacoum rodenticide ingestion in a patient with shigellosis. South Med J. 1997;90:833–5.

    CAS  Article  PubMed  Google Scholar 

  37. Schneider W, Girmann G, Luthe R, Wagner HJ. [Attempted murder with phenprocoumon (marcumar)(author’s transl)]. Dtsch Med Wochenschr. 1975;100:1838–41.

    CAS  Article  PubMed  Google Scholar 

  38. McCurdy W. An attempted homicide using d-CON rat poison. J Anal Toxicol. 1988;12:51–2.

    CAS  Article  PubMed  Google Scholar 

  39. Mack RB. Not all rats have four legs. Superwarfarin poisoning. N C Med J. 1994;55:554–6.

    CAS  PubMed  Google Scholar 

  40. Feinstein DL, Akpa BS, Ayee MA, Boullerne AI, Braun D, Brodsky SV, Gidalevitz D, Hauck Z, Kalinin S, Kowal K, et al. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci. 2016;1374:111–22.

    CAS  Article  PubMed  Google Scholar 

  41. Corke PJ. Superwarfarin (brodifacoum) poisoning. Anaesth Intensive Care. 1997;25:707–9.

    CAS  PubMed  Google Scholar 

  42. Freixo A, Lopes L, Carvalho M, Araujo F. [Superwarfarine Poisoning]. Acta Med Port. 2015;28:389–92.

    Article  PubMed  Google Scholar 

  43. Watson KS, Mills GM, Burton GV. Superwarfarin intoxication: two case reports and review of pathophysiology and patient management. J La State Med Soc. 2012;164:70–2.

    PubMed  Google Scholar 

  44. Cao X, Li L, Zheng Y. Clinical analysis of 12 patients caused by long-acting anticoagulant rodenticide occult poisoning. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37:849–53.

    PubMed  Google Scholar 

  45. Olmos V, Lopez CM. Brodifacoum poisoning with toxicokinetic data. Clin Toxicol (Phila). 2007;45:487–9.

    CAS  Article  Google Scholar 

  46. Nelson AT, Hartzell JD, More K, Durning SJ. Ingestion of superwarfarin leading to coagulopathy: a case report and review of the literature. MedGenMed. 2006;8:41.

    PubMed  PubMed Central  Google Scholar 

  47. Altay S, Cakmak HA, Boz GC, Koca S, Velibey Y. Prolonged coagulopathy related to coumarin rodenticide in a young patient: superwarfarin poisoning. Cardiovasc J Afr. 2012;23:e9–e11.

    Article  PubMed  Google Scholar 

  48. Fisher JA. Playing patient, playing doctor: Munchausen syndrome, clinical S/M, and ruptures of medical power. J Med Humanit. 2006;27:135–49.

    Article  PubMed  Google Scholar 

  49. Zahner J, Schneider W. Munchausen syndrome in hematology: case reports of three variants and review of the literature. Ann Hematol. 1994;68:303–6.

    CAS  Article  PubMed  Google Scholar 

  50. Petersen D, Barthels M. [Factitious disease caused by secret administration of the oral anticoagulant phenprocoumon: study of 16 personal cases]. Med Klin (Munich). 1995;90:277–83.

    CAS  Google Scholar 

  51. Moery S, Pontious JM. Coagulopathy associated with superwarfarin exposure. J Okla State Med Assoc. 2009;102:323–5.

    PubMed  Google Scholar 

  52. Tsutaoka BT, Miller M, Fung SM, Patel MM, Olson KR. Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy. Pharmacotherapy. 2003;23:1186–9.

    Article  PubMed  Google Scholar 

  53. Thomas K. Munchausen syndrome by proxy: identification and diagnosis. J Pediatr Nurs. 2003;18:174–80.

    Article  PubMed  Google Scholar 

  54. Bennett K. Munchausen syndrome by proxy abuse. J Child Health Care. 2000;4:163–6.

    CAS  Article  PubMed  Google Scholar 

  55. Craft AW, Hall DM. Munchausen syndrome by proxy and sudden infant death. BMJ. 2004;328:1309–12.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. Galvin HK, Newton AW, Vandeven AM. Update on Munchausen syndrome by proxy. Curr Opin Pediatr. 2005;17:252–7.

    Article  PubMed  Google Scholar 

  57. Curcic M, Dadasovic J. [Suicide and attempted suicide with rodenticides from 1968 to 2000]. Med Pregl. 2001;54:256–60.

    CAS  PubMed  Google Scholar 

  58. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med. 2003;163:2469–73.

    CAS  Article  PubMed  Google Scholar 

  59. Makris M, Van Veen JJ. Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? Blood Transfus. 2011;9:117–9.

    PubMed  PubMed Central  Google Scholar 

  60. Nee R, Doppenschmidt D, Donovan DJ, Andrews TC. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. Am J Cardiol. 1999;83:286–8. A286-287.

    CAS  Article  PubMed  Google Scholar 

  61. Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999;159:2721–4.

    CAS  Article  PubMed  Google Scholar 

  62. Yiu KH, Siu CW, Jim MH, Tse HF, Fan K, Chau MC, Chow WH. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves. Am J Cardiol. 2006;97:409–11.

    CAS  Article  PubMed  Google Scholar 

  63. Bruno GR, Howland MA, McMeeking A, Hoffman RS. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med. 2000;36:262–7.

    CAS  Article  PubMed  Google Scholar 

  64. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM, British Committee for Standards in Haematology BTTF. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11–28.

    Article  PubMed  Google Scholar 


Page 2

What condition leads to a deficiency in factor IX that can be corrected by an intravenous injection of vitamin K?